BR100 Increased By (0.75%)
BR30 Increased By (0.57%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
AGHA 7.80 Increased By ▲ 0.05 (0.65%)
BECO 5.19 No Change ▼ 0.00 (0%)
BML 57.60 Decreased By ▼ -1.06 (-1.81%)
BOP 34.27 Increased By ▲ 0.58 (1.72%)
CNERGY 10.89 Increased By ▲ 0.28 (2.64%)
CSIL 5.43 Increased By ▲ 0.13 (2.45%)
FCCL 54.85 Increased By ▲ 1.11 (2.07%)
FFL 16.71 Increased By ▲ 0.25 (1.52%)
FNEL 1.23 Increased By ▲ 0.01 (0.82%)
KEL 7.39 Increased By ▲ 0.11 (1.51%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.76 Increased By ▲ 0.11 (0.37%)
MLCF 95.97 Decreased By ▼ -0.39 (-0.4%)
NBP 204.85 Increased By ▲ 1.32 (0.65%)
NCPL 57.71 Increased By ▲ 0.86 (1.51%)
NPL 69.22 Increased By ▲ 1.91 (2.84%)
OGDC 318.40 Increased By ▲ 0.18 (0.06%)
PACE 10.80 Increased By ▲ 0.17 (1.6%)
PAEL 43.10 Increased By ▲ 1.33 (3.18%)
PIBTL 16.89 Increased By ▲ 0.08 (0.48%)
PPL 221.31 Increased By ▲ 1.14 (0.52%)
PRL 51.90 Increased By ▲ 2.85 (5.81%)
PTC 70.90 Increased By ▲ 0.89 (1.27%)
SSGC 29.09 Decreased By ▼ -0.05 (-0.17%)
TBL 9.95 Increased By ▲ 0.18 (1.84%)
TELE 8.86 Increased By ▲ 0.04 (0.45%)
TPL 17.70 Increased By ▲ 0.53 (3.09%)
TPLP 12.90 Increased By ▲ 0.39 (3.12%)
TREET 22.80 Increased By ▲ 0.21 (0.93%)
TRG 59.80 Decreased By ▼ -0.42 (-0.7%)
By

BRUSSELS: A Belgian court ordered AstraZeneca to deliver 50 million doses of its Covid-19 vaccine to EU member states by September 27 — far fewer than Brussels had demanded.

Both sides claimed victory, with the European Commission stressing the firm would pay a financial penalty for each missed dose and the company promising it would easily meet the target.

The UK-based pharmaceutical company fell well short of fulfilling its contract to supply the EU in the first quarter, delivering only 30 million of the 120 million promised.

But the court, while finding in favour of the European Commission’s demand for interim measures, ordered only that the company deliver 50 million more doses by the end of September.

If the firm fails to do so it would pay a fine of 10 euros per dose not delivered.

“This decision confirms the position of the Commission: AstraZeneca did not live up to the commitments it made in the contract,” European Commission President Ursula von der Leyen said. “It is good to see that an independent judge confirms this,” she said.

“This shows that our European vaccination campaign not only delivers for our citizens day by day. It also demonstrates, that it was founded on a sound legal basis.”

Comments

Comments are closed for this article.